Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3452 |  SRZN Surrozen, Inc. - Common Stock | 22.57 USD | -1.91% | -10.86% | +4.93% | +161.53% | 262.05 M USD | ||
| 3459 |  ACIU AC Immune SA - Common Stock | 2.55 USD | +0.39% | +15.91% | +16.44% | +20.85% | 259.44 M USD | ||
| 3474 |  IVVD Invivyd, Inc. - Common Stock | 0.87 USD | -7.45% | +2.35% | -15.53% | +22.54% | 256.31 M USD | ||
| 3480 |  NKTX Nkarta, Inc. - Common Stock | 3.52 USD | +4.14% | +22.65% | +45.45% | +98.87% | 251.84 M USD | ||
| 3487 |  AVXL Anavex Life Sciences Corp. - Common Stock | 2.69 USD | -0.74% | +3.46% | +1.51% | -73.91% | 249.29 M USD | ||
| 3491 |  CHRS Coherus Oncology, Inc. - Common Stock | 1.61 USD | -3.59% | +8.78% | +11.81% | 0.00% | 248.34 M USD | ||
| 3504 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.68 USD | -2.39% | 0.00% | +5.44% | -53.88% | 245.21 M USD | ||
| 3515 |  KPTI Karyopharm Therapeutics Inc. - Common Stock | 10.64 USD | +5.87% | +11.30% | +22.58% | +10.37% | 241.13 M USD | ||
| 3523 |  CDXS Codexis, Inc. - Common Stock | 2.63 USD | +1.15% | +12.88% | +1.15% | -1.87% | 239.06 M USD | ||
| 3533 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 3.93 USD | -0.76% | -7.96% | -1.50% | +34.13% | 235.33 M USD | ||
| 3534 |  DTIL Precision BioSciences, Inc. - Common Stock | 9.12 USD | -1.41% | +17.22% | +30.85% | +102.67% | 235.32 M USD | ||
| 3550 |  TARA Protara Therapeutics, Inc. - Common Stock | 4.12 USD | -3.51% | +8.42% | +0.49% | +35.53% | 231.56 M USD | ||
| 3553 |  ARTV Artiva Biotherapeutics, Inc. - Common Stock | 9.32 USD | -1.69% | -5.09% | +37.67% | +124.04% | 230.36 M USD | ||
| 3557 |  CLLS Cellectis S.A. - American Depositary Shares | 3.20 USD | -0.62% | +8.84% | +5.26% | +103.82% | 229.60 M USD | ||
| 3566 |  CGEN Compugen Ltd. - Ordinary Shares | 2.41 USD | +0.84% | +12.62% | +15.31% | +40.12% | 227.87 M USD | ||
| 3567 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 1.79 USD | +5.92% | -5.79% | -23.50% | +126.58% | 227.47 M USD | ||
| 3573 |  KROS Keros Therapeutics, Inc. - common stock | 11.39 USD | -2.23% | +5.95% | +12.77% | -24.57% | 225.43 M USD | ||
| 3575 |  RNA Atrium Therapeutics, Inc. - Common Stock | 13.14 USD | -0.76% | -2.59% | +13.28% | -81.32% | 224.77 M USD | ||
| 3579 |  NBP NovaBridge Biosciences - American Depositary Shares | 1.94 USD | -3.96% | -2.51% | +20.50% | -56.98% | 223.84 M USD | ||
| 3584 |  VYGR Voyager Therapeutics, Inc. - Common Stock | 3.69 USD | -2.38% | +4.53% | +7.27% | -20.65% | 222.95 M USD |
Notizie Biotechnology Stocks
TD Cowen conferma il Buy su Prime Medicine dopo la vittoria nell’arbitrato
BofA conferma il rating su Beam Therapeutics dopo il lodo arbitrale
Perché il titolo Beam Therapeutics sta scendendo oggi?
Perché il titolo Prime Medicine è in forte rialzo oggi?
Il titolo di Incyte raggiunge il massimo di 52 settimane a 118,77 USD
Il titolo di Prime Medicine sale dopo la vittoria nell’arbitrato contro Beam
Nurix Therapeutics: focus sull’impatto dell’accordo con Roche
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.76 | +53.55% |
 APLMW Apollomics Inc. - Warrant | 0.0161 | +34.17% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.51 | +25.36% |
 PRME Prime Medicine, Inc. - Common Stock | 4.76 | +19.30% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.50 | +14.84% |
 VANI Vivani Medical, Inc. - Common Stock | 1.55 | +14.81% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.70 | +13.33% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.85 | -33.21% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.82 | -21.15% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0139 | -17.26% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.32 | -13.16% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 ONCO Onconetix, Inc. - Common Stock | 0.94 | -12.15% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.18 | -11.79% |